TSCAN THERAPEUTICS, INC..

Company

TScan Therapeutics, Inc.

Filed

June 2, 2023

Accession Number

0000902664-23-003397

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →